What does CUSIP G55598109 represent in this 13F holders report?

CUSIP G55598109 is the security identifier for EVAR - LOMBARD MED INC - COM used to aggregate holder disclosures.

How many institutions held EVAR - LOMBARD MED INC - COM in Q2 2014?

17 institutional investors reported EVAR - LOMBARD MED INC - COM for Q2 2014. Use the holders table for investor-level position and value details.

LOMBARD MED INC - COM (EVAR)

CUSIP: G55598109

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / COM
Total 13F shares: 2,576,182
Share change: +2,576,182
Total reported value: $18,546,040
Price per share: $7.20
Number of holders: 17
Value change: +$18,546,040
Number of buys: 17

Quarterly Holders Quick Answers

What is CUSIP G55598109?
CUSIP G55598109 identifies EVAR - LOMBARD MED INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014

Recent filing periods for CUSIP G55598109:

Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016 Q3 2016 Q2 2016

Institutional Holders of LOMBARD MED INC - COM (EVAR) as of Q2 2014

As of 30 Jun 2014, LOMBARD MED INC - COM (EVAR) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,576,182 shares. The largest 10 holders included Aisling Capital LLC, FIL Ltd, Citadel Advisors LLC, FMR LLC, Alyeska Investment Group, L.P., MORGAN STANLEY, DEUTSCHE BANK AG\, GLG Partners LP, MOORE CAPITAL MANAGEMENT, LP, and UBS OCONNOR LLC. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.